Clinical Trial

Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device

Study acronym: Rx Meds Gaize
Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to verify if the Gaize ocular device can effectively identify eye movements indicative of prescribed psychotropic medication usage by employing Drug Recognition Expert (DRE) testing protocols within a controlled virtual environment.
Trial Details
NCT Number NCT07389473
Lead Sponsor Gaize
Conditions ADHD, Depression Disorders, Mood Disorders, Anxiety Disorder Generalized, Bipolar Disorder (BPD)
Enrollment 50 participants
Start Date 2024-04-17
Primary Completion 2027-12 (estimated)
Study Completion 2028-08 (estimated)
Updated on ClinicalTrials.gov 2026-02-05